[go: up one dir, main page]

TW200815356A - Substituted Cyanopyridines as protein kinase inhibitors - Google Patents

Substituted Cyanopyridines as protein kinase inhibitors Download PDF

Info

Publication number
TW200815356A
TW200815356A TW096121315A TW96121315A TW200815356A TW 200815356 A TW200815356 A TW 200815356A TW 096121315 A TW096121315 A TW 096121315A TW 96121315 A TW96121315 A TW 96121315A TW 200815356 A TW200815356 A TW 200815356A
Authority
TW
Taiwan
Prior art keywords
group
amino
phenyl
alkyl
dimethoxyphenyl
Prior art date
Application number
TW096121315A
Other languages
English (en)
Chinese (zh)
Inventor
Derek Cecil Cole
Magda Asselin
Diane Harris Boschelli
Allan Wissner
Yanong Daniel Wang
Amarnauth Shastrie Prashad
Russell DUSHIN
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200815356A publication Critical patent/TW200815356A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
TW096121315A 2006-06-13 2007-06-13 Substituted Cyanopyridines as protein kinase inhibitors TW200815356A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81318206P 2006-06-13 2006-06-13

Publications (1)

Publication Number Publication Date
TW200815356A true TW200815356A (en) 2008-04-01

Family

ID=38832510

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096121315A TW200815356A (en) 2006-06-13 2007-06-13 Substituted Cyanopyridines as protein kinase inhibitors

Country Status (12)

Country Link
EP (1) EP2027093A2 (es)
JP (1) JP2009539993A (es)
CN (1) CN101454287A (es)
AR (1) AR061367A1 (es)
AU (1) AU2007258352A1 (es)
BR (1) BRPI0712776A2 (es)
CA (1) CA2650666A1 (es)
CL (1) CL2007001738A1 (es)
MX (1) MX2008015805A (es)
PE (1) PE20080369A1 (es)
TW (1) TW200815356A (es)
WO (1) WO2007146323A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
MX2011001319A (es) 2008-08-06 2011-04-05 Vertex Pharma Inhibidores de aminopiridina cinasa.
CN103408489A (zh) * 2013-08-29 2013-11-27 武穴市永宁医药化工有限公司 一种3-氰基吡啶氮氧化物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215823D0 (en) * 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
JP2006512338A (ja) * 2002-12-12 2006-04-13 ファルマシア・コーポレーション マイトジェン活性化プロテインキナーゼ−活性化プロテインキナーゼ−２阻害剤としてのアミノシアノピリジンの使用法
JP2008540656A (ja) * 2005-05-18 2008-11-20 ワイス Ｔｐｌ２キナーゼの３−シアノキノリン阻害物質ならびにそれを製造および使用する方法
PE20080336A1 (es) * 2006-06-13 2008-06-03 Wyeth Corp 3-cianopiridinas sustituidas como inhibidoras de la proteina quinasa

Also Published As

Publication number Publication date
CA2650666A1 (en) 2007-12-21
AR061367A1 (es) 2008-08-20
JP2009539993A (ja) 2009-11-19
MX2008015805A (es) 2009-01-09
WO2007146323A3 (en) 2008-04-17
AU2007258352A1 (en) 2007-12-21
CN101454287A (zh) 2009-06-10
EP2027093A2 (en) 2009-02-25
WO2007146323A2 (en) 2007-12-21
PE20080369A1 (es) 2008-06-04
BRPI0712776A2 (pt) 2013-12-17
CL2007001738A1 (es) 2008-01-18

Similar Documents

Publication Publication Date Title
JP7017521B2 (ja) アクチビン受容体様キナーゼの阻害剤
AU747920B2 (en) Bicyclic pyridine and pyrimidine derivatives as neuropeptide Y receptor antagonists
CN107072985B (zh) 治疗性抑制化合物
CN102099036B (zh) 用于治疗炎性疾患和纤维化疾患的化合物和方法
ES2868355T3 (es) Inhibidores del bromodominio
KR101530117B1 (ko) 야누스 키나제 억제제 화합물 및 방법
CN105283443B (zh) 杂环衍生物及其用途
JP2009023986A (ja) 抗癌剤としてのビアリール誘導体
TW200914443A (en) Process for preparing substituted quinazolinyl furanaldehyde
WO2002032872A1 (fr) Composes a noyau aromatique azote
JP7170996B2 (ja) スルホンアミド誘導体またはその薬学的に許容される酸付加塩
CN107709334A (zh) 新的氨基酸衍生物、其制备方法和包含它们的药用组合物
JP7278273B2 (ja) アクチビン受容体様キナーゼの阻害剤としての置換ピロロピリジン
CN105968115B (zh) 喹啉类化合物、其制备方法、中间体、药物组合物和应用
JP2024056742A (ja) キノリン誘導体から調製される新規な阻害剤
CN111410659B (zh) Pde9抑制剂及其用途
CN115989231B (zh) 一种作为btk抑制剂的化合物及其制备方法与用途
JP7077323B2 (ja) キナゾリン化合物並びにその調製方法、使用及び医薬組成物
CN110248935A (zh) 用于治疗疼痛和疼痛相关病症的含氮二环衍生物
CN105884695B (zh) 杂环衍生物类酪氨酸激酶抑制剂
WO2018214866A1 (zh) 一种氮杂芳基衍生物、其制备方法和在药学上的应用
CN120152972A (zh) 噻二唑衍生物及其组合物和应用
WO2021197250A1 (zh) 作为转染期间重排激酶抑制剂的新的化合物
TW201109336A (en) Inhibitors of JNK
TW200815356A (en) Substituted Cyanopyridines as protein kinase inhibitors